Okitask (Ketoprofen)

Ketoprofen, the active ingredient in Okitask, is a nonsteroidal anti-inflammatory drug (NSAID) presented as a 50 mg tablet for oral use. It is indicated for the relief of mild to moderate pain and inflammation in adults.

GNH USA supplies Okitask as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ketoprofen belongs to the NSAID class and is used to manage inflammatory and painful conditions.

- Rheumatoid arthritis: reduces joint pain, swelling and stiffness. - Osteoarthritis: alleviates chronic joint discomfort and improves mobility. - Acute musculoskeletal pain: provides short‑term relief of sprains, strains and back pain. - Dysmenorrhea: lessens menstrual cramps and associated pelvic pain. - Post‑operative pain: helps control pain after minor surgical procedures.

Ketoprofen may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Gastrointestinal discomfort, such as nausea, dyspepsia or heartburn. - Headache. - Dizziness. - Mild skin rash or itching. - Elevated liver enzymes.

Serious or Rare Side Effects: - Peptic ulcer disease or gastrointestinal bleeding. - Severe skin reactions such as Stevens‑Johnson syndrome. - Hepatotoxicity or marked liver injury. - Renal impairment or acute kidney injury. - Anaphylactic shock or hypersensitivity reactions.

When using Okitask, several safety considerations should be taken into account.

- Assess  ":  ".  \